AUTR yields 335.57% · JNJ yields 2.13%● Live data
📍 AUTR pulled ahead of the other in Year 1
Combined, AUTR + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AUTR + JNJ for your $10,000?
Autris, through its subsidiary, NitroHeat, LLC, assembles and supplies nitrogen generators, air filtration systems, compressed air heaters, and heated hoses. Its products include NitroMax30, a nitrogen generator producing 30cfm of pure nitrogen; HeatPro200, a compressed air heater for heating compressed air or nitrogen up to a maximum of 200f; MaxDry200, a tri stage filter, membrane dryer, and heater that is used to supply clean dry air for painting and other compressed air applications, including powder coating; and heated hoses, a sub component of the HeatPro200 and MaxDry200. The company supplies its products to automotive and industrial paint service providers, and industrial component manufacturers, as well as auto collision facilities through a distributor network in the United States, Canada, Holland, Germany, and China. Autris is based in Los Angeles, California.
Full AUTR Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.